Skip to content

Advanced BioMedical Technologies, Inc.: filings

Every Advanced BioMedical Technologies, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 41 filings, each linked to its SEC index.

Filing record ends 2021-09-13

The latest filing in this captured record is a 10-Q filed 2021-09-13. No later filing is in the SEC companyfacts record captured on 2026-09-22. Advanced BioMedical Technologies, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2021-09-13fiscal Q3 2021391180001493152-21-022511
10-Q2021-06-21fiscal Q2 2021371110001493152-21-014754
10-Q2021-03-22fiscal Q1 202137740001493152-21-006507
10-K2021-01-29fiscal FY 202037740001493152-21-002055
10-Q2020-09-21fiscal Q3 2020361060001493152-20-018065
10-Q/A2020-08-20fiscal Q1 202034640001493152-20-016439
10-Q2020-06-22fiscal Q2 2020361000001493152-20-011580
10-Q2020-04-30fiscal Q1 202034640001493152-20-007409
10-K2020-03-20fiscal FY 201932610001493152-20-004401
10-Q2019-09-20fiscal Q3 201929860001493152-19-014373
10-Q2019-06-19fiscal Q2 201928740001493152-19-009418
10-Q2019-04-01fiscal Q1 201926560001493152-19-004448
10-K/A2019-03-29fiscal FY 201827570001493152-19-004187
10-K2019-02-13fiscal FY 201827570001493152-19-001841
10-Q2018-09-19fiscal Q3 201825710001493152-18-013468
10-Q2018-06-19fiscal Q2 201825710001493152-18-008900
10-Q2018-03-26fiscal Q1 201825530001493152-18-003852
10-K2018-02-13fiscal FY 201728570001493152-18-001918
10-Q2017-09-19fiscal Q3 201726730001387131-17-004713
10-Q2017-06-19fiscal Q2 201726730001387131-17-003313
10-Q2017-03-22fiscal Q1 201725540001387131-17-001563
10-K2017-02-14fiscal FY 201628570001387131-17-000831
10-Q2016-09-14fiscal Q3 201627740001387131-16-006984
10-Q2016-06-20fiscal Q2 201627760001387131-16-005866
10-Q2016-03-21fiscal Q1 201627570001387131-16-004639
10-K2016-02-16fiscal FY 201527540001387131-16-004238
10-Q2015-09-21fiscal Q3 201526700001354488-15-004338
10-Q2015-06-22fiscal Q2 201526700001354488-15-003097
10-Q2015-03-23fiscal Q1 201523480001354488-15-001276
10-K2015-01-29fiscal FY 201426540001354488-15-000348
10-Q2014-09-22fiscal Q3 201420700001354488-14-004705
10-Q2014-06-23fiscal Q2 201420880001354488-14-003388
10-Q2014-03-17fiscal Q1 201420740001354488-14-001202
10-Q2013-09-16fiscal Q3 201320860001354488-13-005225
10-Q2013-06-14fiscal Q2 201320860001354488-13-003480
10-Q2013-03-25fiscal Q1 201321840001354488-13-001462
10-K2013-02-13fiscal FY 201224860001354488-13-000594
10-Q2012-09-19fiscal Q3 201216490001387131-12-003038
10-Q2012-06-19fiscal Q2 201216480001387131-12-001958
10-Q/A2011-10-18fiscal Q3 201114540001387131-11-002258
10-Q2011-09-19fiscal Q3 201114540001387131-11-002099

Inspect the source

Entity
Advanced BioMedical Technologies, Inc. / CIK 0001385799
Captured
SEC response SHA-256
1591f8b0cfab5a80255c1912235608d48fec8b1551b4e091e75b1bc63071e992

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001385799.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))